These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38560117)

  • 1. Enhancing m
    Huang Y; Lv Y; Yang B; Zhang S; Bixia Liu ; Zhang C; Hu W; Jiang L; Chen C; Ji D; Xiong C; Liang Y; Liu M; Ying X; Ji W
    Heliyon; 2024 Apr; 10(7):e28165. PubMed ID: 38560117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of RBM15 as a prognostic biomarker in prostate cancer involving the regulation of prognostic m6A-related lncRNAs.
    Hu B; Lin D; Liu Z; Chen R; Liu J; Wu Y; Wang T
    Eur J Med Res; 2024 Aug; 29(1):411. PubMed ID: 39118157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N6-Methyladenosine enhances the translation of ENO1 to promote the progression of bladder cancer by inhibiting PCNA ubiquitination.
    Shen C; Liu J; Xie F; Yu Y; Ma X; Hu D; Liu C; Wang Y
    Cancer Lett; 2024 Jul; 595():217002. PubMed ID: 38823761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
    Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
    Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of m
    Wu X; Wang S; Wu X; Chen Q; Cheng J; Qi Z
    J Cancer; 2024; 15(7):2045-2065. PubMed ID: 38434979
    [No Abstract]   [Full Text] [Related]  

  • 6. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
    EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL3 Contributes to Osteosarcoma Progression by Increasing DANCR mRNA Stability
    Zhou X; Yang Y; Li Y; Liang G; Kang D; Zhou B; Li Q
    Front Cell Dev Biol; 2021; 9():784719. PubMed ID: 35096816
    [No Abstract]   [Full Text] [Related]  

  • 8. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
    Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RBM15 drives the progression of lung adenocarcinoma by regulating N6-methyladenosine-mediated LDHA mRNA stability.
    Shi S; Wang C; Cai Q; Yang R; Peng M; Liang H; Qian B; Jiang Y; Xiao B; Wang L; Tao Y; Cai J; Zhao Z
    Life Sci; 2024 Dec; 358():123146. PubMed ID: 39406308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LINC00969 modified by METTL3 attenuates papillary thyroid cancer progression in an m6A-dependent manner.
    Huang C; Duan Z; Chen B; Xia H; Wang G
    Adv Clin Exp Med; 2024 Aug; ():. PubMed ID: 39136331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBM15 facilities lung adenocarcinoma cell progression by regulating RASSF8 stability through N6 Methyladenosine modification.
    Ma M; Wang W; Li L; Wang X; Huang Q; Zhou C; Huang Y; Zhao G; Ye L
    Transl Oncol; 2024 Aug; 46():102018. PubMed ID: 38838436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of pathology-specific regulators of m
    Li N; Zhan X
    EPMA J; 2020 Sep; 11(3):485-504. PubMed ID: 32849929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of RNA N6-methyladenosine in primary Sjögren's syndrome.
    Xiao Q; Wu X; Deng C; Zhao L; Peng L; Zhou J; Zhang W; Zhao Y; Fei Y
    Front Med (Lausanne); 2022; 9():959388. PubMed ID: 36465909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis and identification of m
    Huang H; Cui X; Qin X; Li K; Yan G; Lu D; Zheng M; Hu Z; Lei D; Lan N; Zheng L; Yuan Z; Zhu B; Zhao J
    Mol Ther Nucleic Acids; 2022 Mar; 27():577-592. PubMed ID: 35036067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner.
    Han J; Wang JZ; Yang X; Yu H; Zhou R; Lu HC; Yuan WB; Lu JC; Zhou ZJ; Lu Q; Wei JF; Yang H
    Mol Cancer; 2019 Jun; 18(1):110. PubMed ID: 31228940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3-Mediated lncRNA m
    Song Y; Pan Y; Wu M; Sun W; Luo L; Zhao Z; Liu J
    Stem Cell Rev Rep; 2021 Dec; 17(6):2276-2290. PubMed ID: 34505967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
    Kong F; Wang K; Wang L
    Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The M6A methyltransferase METTL3 regulates proliferation in esophageal squamous cell carcinoma.
    Zou J; Zhong X; Zhou X; Xie Q; Zhao Z; Guo X; Duan Y
    Biochem Biophys Res Commun; 2021 Nov; 580():48-55. PubMed ID: 34624569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross talk between RNA N6-methyladenosine methyltransferase-like 3 and miR-186 regulates hepatoblastoma progression through Wnt/β-catenin signalling pathway.
    Cui X; Wang Z; Li J; Zhu J; Ren Z; Zhang D; Zhao W; Fan Y; Zhang D; Sun R
    Cell Prolif; 2020 Mar; 53(3):e12768. PubMed ID: 31967701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine methylation-related genes
    Wang Y; Li T; Liu H; Liang Y; Wang G; Fu G; Takatsuki M; Qu H; Jing F; Li J; Jiang M
    Ann Transl Med; 2022 Dec; 10(24):1398. PubMed ID: 36660669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.